Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2020

Open Access 01-12-2020 | Lung Cancer | Research article

Comorbidities associated with nontuberculous mycobacterial disease in Japanese adults: a claims-data analysis

Authors: Shunsuke Uno, Takanori Asakura, Kozo Morimoto, Kimio Yoshimura, Yoshifumi Uwamino, Tomoyasu Nishimura, Yoshihiko Hoshino, Naoki Hasegawa, Nontuberculous Mycobacteriosis and Bronchiectasis-Japan Research Consortium (NTM-JRC)

Published in: BMC Pulmonary Medicine | Issue 1/2020

Login to get access

Abstract

Background

Nontuberculous mycobacterial (NTM) lung disease is one of a growing number of chronic health problems that is difficult to cure in aging societies. While it is important to be vigilant about associated comorbidities in order to provide better patient care, data on the prevalence of comorbidities stratified by country or region are scarce. We aimed to elucidate the comorbidities associated with NTM disease based on Japanese health insurance claims data.

Methods

Cross-sectional analyses were performed using the claims data for 2014 provided by the Japan Medical Data Center Co., Ltd. Patients aged 20–75 years with ≥3 claims associated with NTM disease were identified and matched to 10 sex-and-age-matched controls that had never made a claim for NTM disease. Thirty-one comorbidities previously suspected to be associated with NTM disease were selected, and the prevalence of these comorbidities compared between cases and controls.

Result

Overall, 419 NTM patients (134 males and 285 females) and 4190 non-NTM controls were identified from the JMDC database. Aspergillosis, asthma, chronic heart failure, diffuse panbronchiolitis, gastroesophageal reflux, interstitial pneumonia, lung cancer, cancer other than breast, lung, ovary, or prostate cancer, and rheumatoid arthritis were associated with NTM disease in both males and females. Chronic obstructive pulmonary disease was associated with NTM in males while chronic kidney disease, osteoporosis, and Sjögren syndrome were associated with NTM in females.

Conclusion

NTM disease was associated with multiple comorbidities that should be considered when providing medical care to individuals with NTM disease.
Literature
1.
go back to reference Namkoong H, Kurashima A, Morimoto K, Hoshino Y, Hasegawa N, Ato M, et al. Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan (1). Emerg Infect Dis. 2016;22(6):1116–7.PubMedPubMedCentralCrossRef Namkoong H, Kurashima A, Morimoto K, Hoshino Y, Hasegawa N, Ato M, et al. Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan (1). Emerg Infect Dis. 2016;22(6):1116–7.PubMedPubMedCentralCrossRef
2.
go back to reference Asakura T, Funatsu Y, Ishii M, Namkoong H, Yagi K, Suzuki S, et al. Health-related quality of life is inversely correlated with C-reactive protein and age in Mycobacterium avium complex lung disease: a cross-sectional analysis of 235 patients. Respir Res. 2015;16:145.PubMedPubMedCentralCrossRef Asakura T, Funatsu Y, Ishii M, Namkoong H, Yagi K, Suzuki S, et al. Health-related quality of life is inversely correlated with C-reactive protein and age in Mycobacterium avium complex lung disease: a cross-sectional analysis of 235 patients. Respir Res. 2015;16:145.PubMedPubMedCentralCrossRef
3.
go back to reference Diel R, Lipman M, Hoefsloot W. High mortality in patients with Mycobacterium avium complex lung disease: a systematic review. BMC Infect Dis. 2018;18(1):206.PubMedPubMedCentralCrossRef Diel R, Lipman M, Hoefsloot W. High mortality in patients with Mycobacterium avium complex lung disease: a systematic review. BMC Infect Dis. 2018;18(1):206.PubMedPubMedCentralCrossRef
4.
go back to reference Tsuji T, Tanaka E, Yasuda I, Nakatsuka Y, Kaji Y, Yasuda T, et al. Nontuberculous mycobacteria in diffuse panbronchiolitis. Respirology. 2015;20(1):80–6.PubMedCrossRef Tsuji T, Tanaka E, Yasuda I, Nakatsuka Y, Kaji Y, Yasuda T, et al. Nontuberculous mycobacteria in diffuse panbronchiolitis. Respirology. 2015;20(1):80–6.PubMedCrossRef
5.
go back to reference Kusumoto T, Asakura T, Suzuki S, Okamori S, Namkoong H, Fujiwara H, et al. Development of lung cancer in patients with nontuberculous mycobacterial lung disease. Respir Investig. 2019;57(2):157–64.PubMedCrossRef Kusumoto T, Asakura T, Suzuki S, Okamori S, Namkoong H, Fujiwara H, et al. Development of lung cancer in patients with nontuberculous mycobacterial lung disease. Respir Investig. 2019;57(2):157–64.PubMedCrossRef
6.
go back to reference Liao TL, Lin CH, Shen GH, Chang CL, Lin CF, Chen DY. Risk for mycobacterial disease among patients with rheumatoid arthritis, Taiwan, 2001-2011. Emerg Infect Dis. 2015;21(8):1387–95.PubMedPubMedCentralCrossRef Liao TL, Lin CH, Shen GH, Chang CL, Lin CF, Chen DY. Risk for mycobacterial disease among patients with rheumatoid arthritis, Taiwan, 2001-2011. Emerg Infect Dis. 2015;21(8):1387–95.PubMedPubMedCentralCrossRef
7.
go back to reference Ringshausen FC, Wagner D, de Roux A, Diel R, Hohmann D, Hickstein L, et al. Prevalence of Nontuberculous mycobacterial pulmonary disease, Germany, 2009-2014. Emerg Infect Dis. 2016;22(6):1102–5.PubMedPubMedCentralCrossRef Ringshausen FC, Wagner D, de Roux A, Diel R, Hohmann D, Hickstein L, et al. Prevalence of Nontuberculous mycobacterial pulmonary disease, Germany, 2009-2014. Emerg Infect Dis. 2016;22(6):1102–5.PubMedPubMedCentralCrossRef
8.
go back to reference Prevots DR, Marras TK. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin Chest Med. 2015;36(1):13–34.PubMedCrossRef Prevots DR, Marras TK. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin Chest Med. 2015;36(1):13–34.PubMedCrossRef
9.
go back to reference Marras TK, Vinnard C, Zhang Q, Hamilton K, Adjemian J, Eagle G, et al. Relative risk of all-cause mortality in patients with nontuberculous mycobacterial lung disease in a US managed care population. Respir Med. 2018;145:80–8.PubMedPubMedCentralCrossRef Marras TK, Vinnard C, Zhang Q, Hamilton K, Adjemian J, Eagle G, et al. Relative risk of all-cause mortality in patients with nontuberculous mycobacterial lung disease in a US managed care population. Respir Med. 2018;145:80–8.PubMedPubMedCentralCrossRef
10.
go back to reference Sekikawa A, Ueshima H, Kadowaki T, El-Saed A, Okamura T, Takamiya T, et al. Less subclinical atherosclerosis in Japanese men in Japan than in white men in the United States in the post-world war II birth cohort. Am J Epidemiol. 2007;165(6):617–24.PubMedPubMedCentralCrossRef Sekikawa A, Ueshima H, Kadowaki T, El-Saed A, Okamura T, Takamiya T, et al. Less subclinical atherosclerosis in Japanese men in Japan than in white men in the United States in the post-world war II birth cohort. Am J Epidemiol. 2007;165(6):617–24.PubMedPubMedCentralCrossRef
11.
go back to reference Abbott RD, Ueshima H, Rodriguez BL, Kadowaki T, Masaki KH, Willcox BJ, et al. Coronary artery calcification in Japanese men in Japan and Hawaii. Am J Epidemiol. 2007;166(11):1280–7.PubMedPubMedCentralCrossRef Abbott RD, Ueshima H, Rodriguez BL, Kadowaki T, Masaki KH, Willcox BJ, et al. Coronary artery calcification in Japanese men in Japan and Hawaii. Am J Epidemiol. 2007;166(11):1280–7.PubMedPubMedCentralCrossRef
12.
go back to reference Hoefsloot W, van Ingen J, Andrejak C, Angeby K, Bauriaud R, Bemer P, et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J. 2013;42(6):1604–13.PubMedCrossRef Hoefsloot W, van Ingen J, Andrejak C, Angeby K, Bauriaud R, Bemer P, et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J. 2013;42(6):1604–13.PubMedCrossRef
13.
go back to reference Jeon K, Kim SY, Jeong BH, Chang B, Shin SJ, Koh WJ. Severe vitamin D deficiency is associated with non-tuberculous mycobacterial lung disease: a case-control study. Respirology. 2013;18(6):983–8.PubMedCrossRef Jeon K, Kim SY, Jeong BH, Chang B, Shin SJ, Koh WJ. Severe vitamin D deficiency is associated with non-tuberculous mycobacterial lung disease: a case-control study. Respirology. 2013;18(6):983–8.PubMedCrossRef
14.
go back to reference Izumi K, Morimoto K, Hasegawa N, Uchimura K, Kawatsu L, Ato M, et al. Epidemiology of adults and children treated for Nontuberculous mycobacterial pulmonary disease in Japan. Ann Am Thorac Soc. 2019;16(3):341–7.PubMed Izumi K, Morimoto K, Hasegawa N, Uchimura K, Kawatsu L, Ato M, et al. Epidemiology of adults and children treated for Nontuberculous mycobacterial pulmonary disease in Japan. Ann Am Thorac Soc. 2019;16(3):341–7.PubMed
15.
go back to reference Lake MA, Ambrose LR, Lipman MC, Lowe DM. “Why me, why now?” using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection. BMC Med. 2016;14:54.PubMedPubMedCentralCrossRef Lake MA, Ambrose LR, Lipman MC, Lowe DM. “Why me, why now?” using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection. BMC Med. 2016;14:54.PubMedPubMedCentralCrossRef
16.
go back to reference Marras TK, Mirsaeidi M, Chou E, Eagle G, Zhang R, Leuchars M, et al. Health care utilization and expenditures following diagnosis of Nontuberculous mycobacterial lung disease in the United States. J Manag Care Spec Pharm. 2018;24(10):964–74.PubMed Marras TK, Mirsaeidi M, Chou E, Eagle G, Zhang R, Leuchars M, et al. Health care utilization and expenditures following diagnosis of Nontuberculous mycobacterial lung disease in the United States. J Manag Care Spec Pharm. 2018;24(10):964–74.PubMed
17.
go back to reference Hwang HJ, Kim MY, Shim TS, Kim DS. Nontuberculous mycobacterial pulmonary infection in patients with idiopathic interstitial pneumonias: comparison with patients without idiopathic interstitial pneumonias. J Comput Assist Tomogr. 2014;38(6):972–8.PubMedCrossRef Hwang HJ, Kim MY, Shim TS, Kim DS. Nontuberculous mycobacterial pulmonary infection in patients with idiopathic interstitial pneumonias: comparison with patients without idiopathic interstitial pneumonias. J Comput Assist Tomogr. 2014;38(6):972–8.PubMedCrossRef
18.
go back to reference Andrejak C, Nielsen R, Thomsen VO, Duhaut P, Sorensen HT, Thomsen RW. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax. 2013;68(3):256–62.PubMedCrossRef Andrejak C, Nielsen R, Thomsen VO, Duhaut P, Sorensen HT, Thomsen RW. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax. 2013;68(3):256–62.PubMedCrossRef
19.
go back to reference Brode SK, Campitelli MA, Kwong JC, Lu H, Marchand-Austin A, Gershon AS, et al. The risk of mycobacterial infections associated with inhaled corticosteroid use. Eur Respir J. 2017;50(3):1700037.PubMedCrossRef Brode SK, Campitelli MA, Kwong JC, Lu H, Marchand-Austin A, Gershon AS, et al. The risk of mycobacterial infections associated with inhaled corticosteroid use. Eur Respir J. 2017;50(3):1700037.PubMedCrossRef
21.
22.
go back to reference Bar-On O, Mussaffi H, Mei-Zahav M, Prais D, Steuer G, Stafler P, et al. Increasing nontuberculous mycobacteria infection in cystic fibrosis. J Cyst Fibros. 2015;14(1):53–62.PubMedCrossRef Bar-On O, Mussaffi H, Mei-Zahav M, Prais D, Steuer G, Stafler P, et al. Increasing nontuberculous mycobacteria infection in cystic fibrosis. J Cyst Fibros. 2015;14(1):53–62.PubMedCrossRef
23.
go back to reference Chao WC, Lin CH, Liao TL, Chen YM, Hsu CY, Chen JP, et al. The risk of nontuberculous mycobacterial infection in patients with Sjogren's syndrome: a nationwide, population-based cohort study. BMC Infect Dis. 2017;17(1):796.PubMedPubMedCentralCrossRef Chao WC, Lin CH, Liao TL, Chen YM, Hsu CY, Chen JP, et al. The risk of nontuberculous mycobacterial infection in patients with Sjogren's syndrome: a nationwide, population-based cohort study. BMC Infect Dis. 2017;17(1):796.PubMedPubMedCentralCrossRef
24.
go back to reference Natalini JG, Johr C, Kreider M. Pulmonary involvement in Sjogren syndrome. Clin Chest Med. 2019;40(3):531–44.PubMedCrossRef Natalini JG, Johr C, Kreider M. Pulmonary involvement in Sjogren syndrome. Clin Chest Med. 2019;40(3):531–44.PubMedCrossRef
25.
go back to reference Dong X, Zhou J, Guo X, Li Y, Xu Y, Fu Q, et al. A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjogren's syndrome-related interstitial lung disease in a Chinese population. Clin Rheumatol. 2018;37(11):2981–8.PubMedCrossRef Dong X, Zhou J, Guo X, Li Y, Xu Y, Fu Q, et al. A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjogren's syndrome-related interstitial lung disease in a Chinese population. Clin Rheumatol. 2018;37(11):2981–8.PubMedCrossRef
26.
go back to reference Mandl T, Diaz S, Ekberg O, Hesselstrand R, Piitulainen E, Wollmer P, et al. Frequent development of chronic obstructive pulmonary disease in primary SS--results of a longitudinal follow-up. Rheumatology (Oxford). 2012;51(5):941–6.CrossRef Mandl T, Diaz S, Ekberg O, Hesselstrand R, Piitulainen E, Wollmer P, et al. Frequent development of chronic obstructive pulmonary disease in primary SS--results of a longitudinal follow-up. Rheumatology (Oxford). 2012;51(5):941–6.CrossRef
27.
go back to reference Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R, Israel HL, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med. 1989;321(13):863–8.PubMedCrossRef Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R, Israel HL, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med. 1989;321(13):863–8.PubMedCrossRef
28.
go back to reference Uwamino Y, Nishimura T, Sato Y, Tamizu E, Asakura T, Uno S, et al. Low serum estradiol levels are related to Mycobacterium avium complex lung disease: a cross-sectional study. BMC Infect Dis. 2019;19(1):1055.PubMedPubMedCentralCrossRef Uwamino Y, Nishimura T, Sato Y, Tamizu E, Asakura T, Uno S, et al. Low serum estradiol levels are related to Mycobacterium avium complex lung disease: a cross-sectional study. BMC Infect Dis. 2019;19(1):1055.PubMedPubMedCentralCrossRef
29.
go back to reference Adas-Okuma MG, Maeda SS, Gazzotti MR, Roco CM, Pradella CO, Nascimento OA, et al. COPD as an independent risk factor for osteoporosis and fractures. Osteoporos Int. Osteoporos Int. 2020;31(4):687–97. Adas-Okuma MG, Maeda SS, Gazzotti MR, Roco CM, Pradella CO, Nascimento OA, et al. COPD as an independent risk factor for osteoporosis and fractures. Osteoporos Int. Osteoporos Int. 2020;31(4):687–97.
30.
go back to reference Lin WY, Lin MS, Weng YH, Yeh TH, Lin YS, Fong PY, et al. Association of Antiviral Therapy with Risk of Parkinson disease in patients with chronic hepatitis C virus infection. JAMA Neurol. 2019;76(9):1019–27. Lin WY, Lin MS, Weng YH, Yeh TH, Lin YS, Fong PY, et al. Association of Antiviral Therapy with Risk of Parkinson disease in patients with chronic hepatitis C virus infection. JAMA Neurol. 2019;76(9):1019–27.
31.
go back to reference Yamazaki K, Macaulay D, Song Y, Sanchez Gonzalez Y. Clinical and economic burden of patients with chronic hepatitis C with versus without antiviral treatment in Japan: an observational cohort study using hospital claims data. Infect Dis Ther. 2019;8(2):285–99.PubMedPubMedCentralCrossRef Yamazaki K, Macaulay D, Song Y, Sanchez Gonzalez Y. Clinical and economic burden of patients with chronic hepatitis C with versus without antiviral treatment in Japan: an observational cohort study using hospital claims data. Infect Dis Ther. 2019;8(2):285–99.PubMedPubMedCentralCrossRef
32.
go back to reference Saeed MJ, Olsen MA, Powderly WG, Presti RM. Diabetes mellitus is associated with higher risk of developing decompensated cirrhosis in chronic hepatitis C patients. J Clin Gastroenterol. 2017;51(1):70–6.PubMedPubMedCentralCrossRef Saeed MJ, Olsen MA, Powderly WG, Presti RM. Diabetes mellitus is associated with higher risk of developing decompensated cirrhosis in chronic hepatitis C patients. J Clin Gastroenterol. 2017;51(1):70–6.PubMedPubMedCentralCrossRef
33.
go back to reference Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53(12):1258–67.PubMedCrossRef Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53(12):1258–67.PubMedCrossRef
Metadata
Title
Comorbidities associated with nontuberculous mycobacterial disease in Japanese adults: a claims-data analysis
Authors
Shunsuke Uno
Takanori Asakura
Kozo Morimoto
Kimio Yoshimura
Yoshifumi Uwamino
Tomoyasu Nishimura
Yoshihiko Hoshino
Naoki Hasegawa
Nontuberculous Mycobacteriosis and Bronchiectasis-Japan Research Consortium (NTM-JRC)
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2020
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-020-01304-6

Other articles of this Issue 1/2020

BMC Pulmonary Medicine 1/2020 Go to the issue